At Mandashi, our focus is on helping innovative businesses achieve their full potential. Today, we’re thrilled to highlight the amazing journey of Atelerix, a pioneering biotech company that has just secured significant further investment to revolutionise the transport and storage of biological materials.
Atelerix has developed cutting-edge biotechnology that encapsulates cells, tissue, and other biological materials in hydrogels, enabling safe, prolonged storage and transport without the need for freezing. This advancement has profound implications and benefits for research, diagnostics, and healthcare.
We have been collaborating with Atelerix since 2023 both in terms of investing in their business and team, but also in helping connect them with a network of investors and experts to secure funding for their groundbreaking technology. It's therefore fantastic news to be able to report the successful further raise of £750,000 that will empower Atelerix to further its mission and expand its impact across the biotech landscape.: https://www.atelerix.co.uk/blogs/news/atelerix-raises-750k-to-revolutionise-biological-transport
We look forward to seeing Atelerix continue to lead the way in revolutionising the logistics of biological materials. Congratulations to the entire Atelerix team—we’re excited to see what the future holds!
Comments